Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients

Mario Scartozzi, Riccardo Giampieri, Elena Maccaroni, +7

British Journal of Cancer

Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients

Chiara Braconi, R. Bracci, Italo Bearzi, +7

Annals of Oncology

Disease OutcomeGrowth HormoneInsulin-like Growth FactorDiabetesPathology +4

The Role of LDH Serum Levels in Predicting Global Outcome in HCC Patients Undergoing TACE: Implications for Clinical Management

Mario Scartozzi, Luca Faloppi, Maristella Bianconi, +8

PLoS ONE

PathologyLdh Serum LevelsTumor BiologyHcc PatientsHepatobiliary Tumor +14

Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features

Laura Belvederesi, Francesca Bianchi, Cristian Loretelli, +7

European Journal of Human Genetics

Cancer PathologyFunctional FeaturesMedicineGeneticsGenetic Epidemiology +10

CAT25 Is a Mononucleotide Marker to Identify HNPCC Patients

Francesca Bianchi, Romina Catalani, Laura Belvederesi, +3

Journal of Molecular Diagnostics

Mononucleotide MarkerGenetic DisorderMedicineGeneticsGenetic Epidemiology +4

Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: are all mutations equal?

Elena Maccaroni, R. Bracci, Riccardo Giampieri, +7

Oncotarget

<i>MSH2</i>missense mutations and HNPCC syndrome: pathogenicity assessment in a human expression system

Laura Belvederesi, Francesca Bianchi, Cristian Loretelli, +4

Human Mutation

GeneticsPathologyDisease Gene IdentificationPathogenicity AssessmentHuman Expression System +14

An intronic mutation in MLH1 associated with familial colon and breast cancer

Francesca Bianchi, Michela Raponi, Francesco Piva, +9

Familial Cancer

Cancer PathologyGeneticsFamilial ColonPathologyGenomics +15

Role of Vascular Endothelial Growth Factor (VEGF) and VEGF-R Genotyping in Guiding the Metastatic Process in pT4a Resected Gastric Cancer Patients

Mario Scartozzi, Cristian Loretelli, Alessandra Mandolesi, +10

PLoS ONE

Surgical OncologyAngiogenesisAc GenotypeAa GenotypeGastrointestinal Oncology +13

BRCA1 expression in triple negative sporadic breast cancers.

Gessica Giorgetti, Gina Piccinini, Alfredo Santinelli, +10

PubMed